ClinicalTrials.gov
ClinicalTrials.gov Menu

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00662181
Recruitment Status : Unknown
Verified April 2008 by Hvidovre University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : April 21, 2008
Last Update Posted : April 21, 2008
Sponsor:
Information provided by:
Hvidovre University Hospital

April 16, 2008
April 21, 2008
April 21, 2008
May 2008
October 2008   (Final data collection date for primary outcome measure)
Quality of life [ Time Frame: 6 months follow-up ]
Same as current
No Changes Posted
Metabolism [ Time Frame: 6 months follow-up ]
Same as current
Not Provided
Not Provided
 
Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone
A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.
Not Provided
Observational
Not Provided
Not Provided
Not Provided
Non-Probability Sample
Participants from the HIGH: low study
  • HIV Infections
  • HIV-Associated Lipodystrophy Syndrome
Not Provided
H, NH
HIV positive patients with and without lipodystrophy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
46
Same as current
January 2009
October 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • over 18 years of age
  • Participated in and completed the HIGH: low study
  • informed consent signed

Exclusion Criteria:

  • Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study
Sexes Eligible for Study: Male
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00662181
H-B-2008-053
2008-41-2145
Yes
Not Provided
Not Provided
Forskningschef Ove Andersen, Klinisk Forskningscenter, Hvidovre Hospital
Hvidovre University Hospital
Not Provided
Principal Investigator: Ove Andersen, MD Klinisk Forskningcenter, Hvidovre Hospital
Hvidovre University Hospital
April 2008